We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arbutus Biopharma Corporation | NASDAQ:ABUS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.80 | 2.80 | 3.00 | 0 | 10:05:35 |
| | |
Page
|
| |||
| | | | S-ii | | | |
| | | | S-ii | | | |
| | | | S-1 | | | |
| | | | S-3 | | | |
| | | | S-6 | | | |
| | | | S-8 | | | |
| | | | S-9 | | | |
| | | | S-11 | | | |
| | | | S-13 | | | |
| | | | S-20 | | | |
| | | | S-20 | | | |
| | | | S-20 | | | |
| | | | S-20 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 11 | | | |
| | | | 12 | | | |
| | | | 17 | | | |
| | | | 18 | | | |
| | | | 21 | | | |
| | | | 21 | | | |
| | | | 21 | | |
|
Assumed public offering price per share
|
| | | | | | | | | $ | 3.64 | | |
|
Net tangible book value per share as of December 31, 2020
|
| | | $ | 1.14 | | | | | | | | |
|
Increase in tangible book value per share attributable to shares sold pursuant to the Sale
Agreement from January 1, 2021 to March 4, 2021 |
| | | $ | 0.18 | | | | | | | | |
|
Pro forma net tangible book value per share as of December 31, 2020
|
| | | $ | 1.32 | | | | | | | | |
|
Increase in pro forma net tangible book value per share after this offering
|
| | | $ | 0.39 | | | | | | | | |
|
Pro forma as adjusted net tangible book value per share as of December 31, 2020, after giving effect to this offering
|
| | | | | | | | | $ | 1.71 | | |
|
Dilution per share to new investors in this offering(1)(2)
|
| | | | | | | | | $ | 1.93 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 11 | | | |
| | | | 12 | | | |
| | | | 17 | | | |
| | | | 18 | | | |
| | | | 21 | | | |
| | | | 21 | | | |
| | | | 21 | | |
1 Year Arbutus Biopharma Chart |
1 Month Arbutus Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions